Showing results (271-280 of 282) with videos related to
Sort By:
Pageof 29
Nature Communications|June 9, 2021
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, SwitzerlandSilvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.Cell Stem Cell|July 19, 2016
Molecular Criteria for Defining the Naive Human Pluripotent StateThorold W Theunissen, Marc Friedli, Yupeng He, et al.Cell Stem Cell|October 8, 2021
A cis-acting structural variation at the ZNF558 locus controls a gene regulatory network in human brain developmentPia A Johansson, Per Ludvik Brattås, Christopher H Douse, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2005
Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal miceMike Themis, Simon N Waddington, Manfred Schmidt, et al.The Journal of Infection|October 18, 2023
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeysCraig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.Nature Microbiology|July 25, 2022
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeysCraig Fenwick, Priscilla Turelli, Dongchun Ni, et al.Nature Communications|March 12, 2020
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomesChloe Chong, Markus Müller, HuiSong Pak, et al.Lancet (London, England)|June 15, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studySilvia Stringhini, Ania Wisniak, Giovanni Piumatti, et al.Nature|April 26, 2023
De novo design of protein interactions with learned surface fingerprintsPablo Gainza, Sarah Wehrle, Alexandra Van Hall-Beauvais, et al.Cell Reports|October 2, 2021
A highly potent antibody effective against SARS-CoV-2 variants of concernCraig Fenwick, Priscilla Turelli, Laurent Perez, et al.Pageof 29